ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,034.91
-0.30%
US Tech 100
20,834.00
-0.29%
Dow Jones
44,247.83
-0.35%
Brent Oil
72.545
0.84%
Bitcoin
97,646.97
1.00%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. PHAXIAM Therapeutics SA (PHXM) Quote

PHAXIAM Therapeutics SA

PHAXIAM Therapeutics SA (PHXM)

EU
1.73
0.00
(0.00%)
Closed December 11 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.73
Bid
1.702
Ask
1.85
Volume
0.00
0.00 Day's Range 0.00
1.50 52 Week Range 5.00
Market Cap
53.612M
Previous Close
1.73
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
15,098
Shares Outstanding
30,989,584
Dividend Yield
-
PE Ratio
-2.28
Earnings Per Share (EPS)
-0.76
Revenue
1.33M
Net Profit
-23.49M

About PHAXIAM Therapeutics SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.phaxiam.com
Headquarters
Lyon, Rhone, Fra
Founded
-
PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.73 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 5.00 €.

PHAXIAM Therapeutics currently has 30,989,584 shares outstanding. The market capitalization of PHAXIAM Therapeutics is 53.61 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.28.

Ask ADVFN Intelligence (AI)

PHXM Latest News

More News

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

December 05 2024
UK Regulatory

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

December 05 2024
UK Regulatory

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie Tenue d’un webinaire le 27 novembre 2024 « Evolving strategic...

November 27 2024
UK Regulatory

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area Webinar being held today "Evolving strategic context for phages...

November 27 2024
UK Regulatory

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day »

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day » PHAXIAM a présenté son test IVD Phagogramme et l’actualisation...

November 18 2024
UK Regulatory

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" This event, organized in collaboration with Phage Canada and bringing together...

November 18 2024
GlobeNewswire Inc.

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility...

November 18 2024
UK Regulatory

PHAXIAM Reports Third-Quarter 2024 Financial Information

PHAXIAM Reports Third-Quarter 2024 Financial Information Cash and cash equivalents of €5.7 million as of September 30, 2024Execution of clinical strategy as planned, with the GLORIA global Phase...

November 13 2024
UK Regulatory

PHAXIAM publie l’information financière du troisième trimestre 2024

PHAXIAM publie l’information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie de 5,7 M€ au 30 septembre 2024Exécution de la stratégie clinique conforme au plan, avec...

November 13 2024
UK Regulatory

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024 Information mensuelle relative au nombre total de droits de vote et...

November 08 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.021.169590643271.711.781.62118291.71990711DE
4-0.02-1.142857142861.751.781.5185391.65553105DE
120.084.848484848481.652.1451.5150981.75099783DE
26-1.21-41.1564625852.9431.5114481.84986047DE
52-2.84-62.14442013134.5751.585692.32734232DE
1560.94118.9873417720.7960.353262231.18712896DE
2600.94118.9873417720.7960.353262231.18712896DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABEOABEO SA
10.20 €
(0.00%)
0
ABCAABC Arbitrage
4.725 €
(0.00%)
0
ABAb Science
0.78 €
(0.00%)
0
AALBAalberts NV
36.90 €
(0.00%)
0
AAAAlan Allman Associates
3.46 €
(0.00%)
0
ABEOABEO SA
10.20 €
(0.00%)
0
ABCAABC Arbitrage
4.725 €
(0.00%)
0
ABAb Science
0.78 €
(0.00%)
0
AALBAalberts NV
36.90 €
(0.00%)
0
AAAAlan Allman Associates
3.46 €
(0.00%)
0
ABEOABEO SA
10.20 €
(0.00%)
0
ABCAABC Arbitrage
4.725 €
(0.00%)
0
ABAb Science
0.78 €
(0.00%)
0
AALBAalberts NV
36.90 €
(0.00%)
0
AAAAlan Allman Associates
3.46 €
(0.00%)
0

Discussion

View Full Feed
Money hunt Money hunt 9 minutes ago
These clowns lost all their believers, No interest touching this garbage with a 10 foot pole.
RNAZ
trender18 trender18 9 minutes ago
FWIW: https://www.facebook.com/reel/4706495349575600
NFTM
weedtrader420 weedtrader420 9 minutes ago
XRP QUANTUM NEWCLEUS COMPUTER AGE ( push the button )
XRPUSD
k9uwa k9uwa 14 minutes ago
file not touched on a day is not counted. That is a flat out LIE. Days that count are Work Days. Days that do not count are Weekends Holidays. Not just days the Rapporteurs take off just because they don't want to work that day or do not have any additional work that day. For that one you should be
AVXL
Louinjaxxx Louinjaxxx 14 minutes ago
Shortsighted, huh?
AXXA
gitreal gitreal 17 minutes ago
DD that is limited to company PRs and social media posts by promoters.....is not DD. It's a recipe for financial loss.

DD is calling up the BLM, the County Water Quality Control Board, or MSHA....and asking about the status of the permitting for the Bishop Mill. Same for the Mt.
NBRI
weedtrader420 weedtrader420 21 minutes ago
RIPPLECOIN XRP Million Little Miracles $4 TARGET
XRPUSD
weedtrader420 weedtrader420 26 minutes ago
☝️🤑☝️
XRPUSD
CrimsonNightRider CrimsonNightRider 30 minutes ago
Audit scam? Soon. Yeah soon. Sure.

https://investorshub.advfn.com/uimage/uploads/2024/11/21/zziuwIMG_2735.jpeg
EDXC
CrimsonNightRider CrimsonNightRider 32 minutes ago
Funny manlet.
IQST
CrimsonNightRider CrimsonNightRider 35 minutes ago
Why?
ASTA
JohnnyHydrogen JohnnyHydrogen 36 minutes ago
Mr. Wondrrful's plan. Game-Changer? The video seems to imply it:

https://x.com/i/status/1866182342290645499

After watching this video, I believe that this project will likely involve Nat Gas and carbon capture for primary power. Likely Nat Gas fuel cells for back-up pow
FCEL
lakers17 lakers17 38 minutes ago
Congrats on your pump from .021 to .0006. Brilliant. How much are you down? NSAV now has a yield sign and no extension filed for their filing. where is your accountant? Did he really leave as well. NSAV will see the expert market soon, the kiss of death. They have no money to pay for anythi
BCDS NSAV
againstallodds againstallodds 39 minutes ago
How about you learn to do DD???

Search Mt Washington BC copper pollution on salmon and remediation efforts.

Then we can talk seriously
NBRI
Genz2 Genz2 40 minutes ago
https://cybernews.com/security/doj-indicts-ofac-sanctions-chinese-hacker-exploits-sophos-firewalls-/

Wave said a long time ago that organizations should be using Wave instead of firewalls!! Isn’t much of Palo Alto’s security using firewalls?? When will the market ever learn to use W
Konaploinks Konaploinks 40 minutes ago
So now we know that Michael Dell, Marc Benioff , Bill Gates and Google are all investors in IonQ. They all definitely have their eye on IonQ. Shares held by institutions 32.64 % . Only 216.4 million shares outstanding. That’s not very many when you remove institutional and insiders shares which is a
IONQ
barnstormer barnstormer 41 minutes ago
Gary, since you were talking about your daughters, I wondered if it was possible to set up Roths for them, even if they have their own. AI response was that it was possible to do so. Might be worth looking at as a way to move some NWBO their way.
NWBO
littlejohn littlejohn 44 minutes ago
SMCI Liquid Cooled System for Ai Compute Density...

https://finance.yahoo.com/news/supermicro-delivers-direct-liquid-optimized-183500750.html

Advances in their Direct Liquid Cooling

systems since summer, 2024 have

came at a fast pace...
SMCI
Steady_T Steady_T 46 minutes ago
Guess again Kund. The EMA counts work days i.e. days that the employees are at work, so weekends and holidays do not count against the 210 day time line.

It is not " if the file is not touched on a given day, that day is not counted." That suggests a file could sit in an in box and no
AVXL
skitahoe skitahoe 48 minutes ago
You're right, the UK and European 150 days to evaluate regulatory filings seem to be almost meaningless, but Europe did ask for this, I believe they could act in a timely way.

Now timely, in there case could be 150 days, plus 60 or more after RFI's, but sometime next year is very poss
AVXL
Konaploinks Konaploinks 51 minutes ago
HOMEWORK FROM CHATGPT
Yes, Google and IonQ are partners in the quantum computing ecosystem. IonQ’s quantum computers are available on Google Cloud, among other major cloud platforms like Amazon Web Services and Microsoft Azure. This collaboration allows users to access IonQ’s advanced quantum
IONQ
rodeoup rodeoup 51 minutes ago
Thanks bro for your concerns, but naturally I couldn’t care less what you think about my investing patterns with Jared and company.
NBRI
GoldenTicketHunter GoldenTicketHunter 54 minutes ago


Address in SC is for a $2million 6 bedroom home owned
KRTL
YY1000 YY1000 55 minutes ago
Go to dictionary.com. Type in "c-o-u-n-t-e-r-o-f-f-e-r" (without the dashes).
You will get:
"counteroffer
[ koun-ter-aw-fer, -of-er, koun-ter-aw-fer, -of-er ]
noun
an offer or proposal made to offset or substitute for an earlier offer made by another."
RVNC

Your Recent History

EU
PHXM
PHAXIAM Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved